(Q44235049)

1 December 2017

title

PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects (English)

1 reference

human subject research project

1 December 2017

main subject

0 references

2

Halldin C

1 reference

1 December 2017

Gulyás B

1

1 reference

1 December 2017

Sandell J

3

1 reference

1 December 2017

Karlsson P

4

1 reference

1 December 2017

Sóvágó J

5

1 reference

1 December 2017

Kárpáti E

6

1 reference

1 December 2017

Kiss B

7

1 reference

1 December 2017

Vas A

8

1 reference

1 December 2017

Cselényi Z

9

1 reference

1 December 2017

Farde L

10

1 reference

1 December 2017

language of work or name

non-English

0 references

publication date

1 December 2002

1 reference

Acta Neurologica Scandinavica

1 December 2017

published in

1 reference

1 December 2017

volume

106

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

325-332

1 reference

Role of sodium channel inhibition in neuroprotection: effect of vinpocetine

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Neurotrophin-mediated neuroprotection by solid fetal telencephalic graft in middle cerebral artery occlusion: a preventive approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

The use of Xenopus oocytes to evaluate drugs affecting brain Ca2+ channels: effects of bifemelane and several nootropic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Indole derivatives as neuroprotectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: a PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

The neuroprotective drug vinpocetine prevents veratridine-induced [Na+]i and [Ca2+]i rise in synaptosomes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Synaptosomal response to oxidative stress: effect of vinpocetine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Human brain atlas: For high-resolution functional and anatomical mapping

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Excitatory Amino Acid, GABAA, and GABAB Binding Sites in Human Striate Cortex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Distribution and plasticity of immunocytochemically localized GABAA receptors in adult monkey visual cortex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Pre- and postnatal development of GABA receptors in Macaca monkey visual cortex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Quantitation in positron emission computed tomography: 5. Physical--anatomical effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

Positron emission tomography studies of dopamine-enhancing drugs.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.01302.X

7 January 2021

10.1034/J.1600-0404.2002.01302.X

Identifiers

DOI

1 reference

1 December 2017

1 reference